Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,212
Funds Holding Change
+32
Funds Holding Growth
+0.6%
Value
$1.53T
Holding in Top 10
815
Top 10 Change
-18
Top 10 Growth
-2%
Value Growth
+8%
New
194
Increased
2,407
Reduced
2,261
Closed
100
Capital Inflow
$42B
Capital Outflow
$32.8B
Net Capital Flow
+$9.13B
Capital Flow Change
-$3.16B
Calls
$21.1B
Puts
$21B
Net Calls
+$160M
Put/Call Ratio
0.99